CURLF
Curaleaf Holdings

8,714
Loading...
Loading...
News
all
press releases
Should You Buy or Sell CURLF Stock Amid Renewed Legalization Hopes?
Curaleaf's shares have soared over 200% on renewed legalization optimism, but domestic weakness and profit hurdles cloud the outlook.
Zacks·3d ago
News Placeholder
More News
News Placeholder
Tilray, Canopy Growth: Cannabis Stocks Lose High Premarket After Surge Triggered By Trump's Post
Major weed stocks rallied the previous day after President Donald Trump's post, which highlighted the potential benefits of using cannabidiol in senior healthcare.
Stocktwits·11d ago
News Placeholder
Green Thumb Launches $50M Buyback: Time to Get Bullish on the Stock?
GTBIF launches a $50 million share buyback program, signaling confidence in long-term growth despite market and pricing pressures.
Zacks·24d ago
News Placeholder
Cannabis Stock CRLBF Gains 25% in a Month: Time to Buy, Sell or Hold?
CRLBF surges 25% this month on reform hopes, but revenue declines, margin pressure and stiff competition cloud its outlook.
Zacks·1mo ago
News Placeholder
Cannabis Stock CRON Trades Near 52-Week High: How to Play
Cronos trades near its 52-week high as international growth boosts sales, but losses and stiff competition weigh on its outlook.
Zacks·1mo ago
News Placeholder
Cannabis Stock VRNOF Soars 178% in a Month: Time to Buy, Sell or Hold?
Verano's stock has surged 178% in a month on reform hopes, but pricing pressure and stiff competition test its momentum.
Zacks·1mo ago
News Placeholder
Trump Confirms Marijuana Reclassification Decision To Be Made In ‘Next Few Weeks’
The President noted that there’s a difference of opinion on the benefits of marijuana, but added that he’s heard “great things” with respect to medical marijuana, specifically.
Stocktwits·2mo ago
News Placeholder
Curaleaf Holdings, Inc. (CURLF) Reports Q2 Loss, Misses Revenue Estimates
Curaleaf Holdings, Inc. (CURLF) delivered earnings and revenue surprises of +14.29% and -0.26%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?
Zacks·2mo ago
News Placeholder
Should You Buy, Hold or Sell TLRY Stock Post Q4 Earnings Release?
Tilray posts record non-cannabis revenues in fiscal 2025, but Q4 sales slip as cannabis weakness pressures overall results.
Zacks·2mo ago
News Placeholder
Baxter International (BAX) Misses Q2 Earnings and Revenue Estimates
Baxter (BAX) delivered earnings and revenue surprises of -1.67% and -0.28%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?
Zacks·2mo ago

Latest CURLF News

View

Advertisement|Remove ads.

Advertisement|Remove ads.